Beacon Pointe Advisors’s Anavex Life Sciences AVXL Stock Holding History

Beacon Pointe Advisors’s Portfolio AVXL Stock Details AVXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$60K	Buy	23,185 +185	+0.8%	+$547	﹤0.01%	1890
2026 Q1	$70.6K	Hold	23,000	–	–	﹤0.01%	1801
2025 Q4	$81.9K	Hold	23,000	–	–	﹤0.01%	1473
2025 Q3	$205K	Hold	23,000	–	–	﹤0.01%	1315
2025 Q2	$212K	Hold	23,000	–	–	﹤0.01%	1172
2025 Q1	$197K	Hold	23,000	–	–	﹤0.01%	1157
2024 Q4	$247K	Hold	23,000	–	–	﹤0.01%	1080
2024 Q3	$131K	Hold	23,000	–	–	﹤0.01%	1185
2024 Q2	$97.1K	Buy	23,000 +5,000	+28%	+$20.2K	﹤0.01%	1229
2024 Q1	$91.6K	Hold	18,000	–	–	﹤0.01%	1313
2023 Q4	$168K	Sell	18,000 -225	-1%	-$1.55K	﹤0.01%	1249
2023 Q3	$119K	Buy	18,225 +225	+1%	+$1.79K	﹤0.01%	1270
2023 Q2	$146K	Hold	18,000	–	–	﹤0.01%	1031
2023 Q1	$154K	Hold	18,000	–	–	﹤0.01%	1086
2022 Q4	$167K	Hold	18,000	–	–	﹤0.01%	1005
2022 Q3	$186K	Hold	18,000	–	–	﹤0.01%	934
2022 Q2	$180K	Hold	18,000	–	–	﹤0.01%	977
2022 Q1	$222K	Sell	18,000 -225	-1%	-$2.77K	﹤0.01%	1087
2021 Q4	$316K	Hold	18,225	–	–	0.01%	713
2021 Q3	$327K	Hold	18,225	–	–	0.01%	673
2021 Q2	$417K	Hold	18,225	–	–	0.01%	546
2021 Q1	$272K	Hold	18,225	–	–	0.02%	407
2020 Q4	$98K	Buy	+18,225	New	+$96K	0.01%	495

Other funds holding AVXL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Beacon Pointe Advisors's AVXL Position: Q2 2026 in Review

Beacon Pointe Advisors increased its Anavex Life Sciences (AVXL) stake by 0.8% in Q2 2026, buying an estimated $547 and bringing the position to 23,185 shares worth $60K. The position accounts for ﹤0.01% of the portfolio, ranked #1890.

Beacon Pointe Advisors first reported a position in AVXL in Q4 2020 and has held it in 23 quarters since. The position peaked at $417K in Q2 2021. 179 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

Beacon Pointe Advisors held 23,185 shares of Anavex Life Sciences worth $60K as of Q2 2026.
Beacon Pointe Advisors bought 185 Anavex Life Sciences shares in Q2 2026, an estimated $547.
Anavex Life Sciences made up ﹤0.01% of Beacon Pointe Advisors's portfolio in Q2 2026, its #1890 holding.
Beacon Pointe Advisors first reported a position in Anavex Life Sciences in Q4 2020 and has held it in 23 quarters since.
Beacon Pointe Advisors's Anavex Life Sciences position peaked at $417K in Q2 2021.
179 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on Beacon Pointe Advisors's 13F filing for Q2 2026, filed 18 Aug 2026.